Three of the top diabetes tech companies put forward new clinical data this week, making the case for their continuous glucose monitors and insulin pumps as they look to expand their reac | Three ...

A quarter of a century after IBM released the last official version of OS/2, someone is still keeping the platform alive under the ArcaOS name. Arca ...

Abbott (NYSE:ABT) today announced results from a trial demonstrating better glucose outcomes for users of continuous glucose monitors (CGMs).

For an estimated 11% of Americans over age 65 who have dementia and the over 11 million unpaid caregivers supporting them, there is no instruction manual for navigating life after diagnosis. A team of ...